Gerresheimer at the PDA Parenteral Packaging Conference in Phoenix Arizona
28 March 2012 | By Gerresheimer AG
Gerresheimer will display its comprehensive range of tubular glass...
List view / Grid view
28 March 2012 | By Gerresheimer AG
Gerresheimer will display its comprehensive range of tubular glass...
28 March 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company and Meso Scale Discovery have entered an agreement...
28 March 2012 | By Merck
The DSMB of the IMPROVE-IT trial has completed the second pre-specified interim efficacy analysis of the study...
28 March 2012 | By Merck
Long-time Merck and Schering-Plough Executive Richard S. Bowles to retire...
28 March 2012 | By Novartis
Collaboration with the Broad Institute yields comprehensive encyclopedia of genetic and molecular information...
27 March 2012 | By Andrew Lloyd & Associates
Novasep announces the opening of a new 2,000 m2 facility in Shanghai Pudong district...
27 March 2012 | By College Hill
Activiomics Limited., the developer of innovative biomarker technologies has announced the appointment of industry leader Dr Trevor Nicholls to its Board as Non-Executive Chairman.
26 March 2012 | By AstraZeneca
The US District Court for the District of Columbia issued an opinion and order in AstraZeneca’s lawsuit...
26 March 2012 | By Sanofi
Data from two Phase 2 trials announced...
26 March 2012 | By Teva Pharmaceutical Industries Ltd
New treatment with “dry” mode of delivery seeks to address unmet needs of seasonal and perennial allergy sufferers...
25 March 2012 | By Amgen
Robust AMG 145 Phase 2 program expected to deliver results in 2012...
24 March 2012 | By Merck
Results from TRA-2P study - published...
23 March 2012 | By GlaxoSmithKline
COPD and asthma regulatory plans remain on track for submission from mid-2012...
23 March 2012 | By Amylin Pharmaceuticals, Inc.
Patients in pivotal study achieved better glycemic control overall and after meals...
22 March 2012 | By Catalent Pharma Solutions
Catalent Pharma Solutions announces the completion of new Development and Analytical Solutions’ laboratories at its facility in Swindon, UK.